Application

14455847 · ADMINISTRATION OF KARENITECIN FOR THE TREATMENT OF ADVANCED OVARIAN CANCER, INCLUDING CHEMOTHERAPY-RESISTANT AND/OR THE MUCINOUS ADENOCARCINOMA SUB-TYPES

Filed 2014-08-08 · Abandoned The official file ↗ · Art unit 1642 · Examiner Julie Zhen Qin Wu Typical · CPC A61K 31/695 · BioNumerik Pharmaceuticals, Inc. · BioNumerik Pharmaceuticals, Inc.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

21.0 mo

to disposition 62.7 mo

Statutes raised

102 103 112 DP

4 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.